L’Oréal’s Anthelios SX Will Launch Following FDA Approval Of UVA Filter
This article was originally published in The Tan Sheet
Executive Summary
L'Oréal will introduce Anthelios SX, the first product on the U.S. market containing a sun filter for short UVA wave protection, this fall, the company announced July 24
You may also be interested in...
FDA Denies Remaining Sunscreen TEAs, Offers Primer On GRASE, Resources
FDA denies sunscreen TEAS for L'Oreal and Merck & Co., citing data gaps, according to proposed orders. Proponents of launching additional ingredients say the decisions point to continued gridlock in changing FDA’s OTC sunscreen monograph.
FDA Denies Remaining Sunscreen TEAs, Offers Primer On GRASE, Resources
FDA denies sunscreen TEAS for L'Oreal and Merck & Co., citing data gaps, according to proposed orders. Proponents of launching additional ingredients say the decisions point to continued gridlock in changing FDA’s OTC sunscreen monograph.
PLx Pharma Proposes “GI-Safer” OTC Aspirin In New Drug Application
The firm files a rare new drug application for an OTC product, a formulation of aspirin and phosphatidylcholine designed to be more tolerable to the gastrointestinal tract. The involvement of OTC veterans Peter Mann and Michael Valentino on PLx’s board suggests strong market potential.